Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Conditions
Interventions
ORACEA®
Placebo
Locations
37
United States
Macula and Retina Institute
Glendale, California, United States
Retina Consultants of San Diego
Poway, California, United States
Colorado Retina Associates, PC
Golden, Colorado, United States
Eldorado Retina Associates
Louisville, Colorado, United States
New England Retina Associates
Hamden, Connecticut, United States
George Washington University
Washington D.C., District of Columbia, United States
Start Date
February 1, 2013
Primary Completion Date
November 1, 2020
Completion Date
November 1, 2020
Last Updated
November 4, 2022
NCT07230834
NCT07392255
NCT06779773
NCT06990269
NCT06970665
NCT07160179
Lead Sponsor
Paul Yates, MD, PhD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions